Patents by Inventor Terence Rabbits

Terence Rabbits has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LMO2 PROTEIN INHIBITORS
    Publication number: 20230303544
    Abstract: The present invention relates to compounds of Formula (I) that function as LMO2 activity: Formula (I) wherein R1, X1, X2, X3, Q, R2, R3 and R4 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which LMO2 activity is implicated.
    Type: Application
    Filed: August 18, 2021
    Publication date: September 28, 2023
    Inventors: Terence Rabbits, Nicolas Bery, Carole Bataille, Angela Russell
  • Selection of intracellular immunoglobulins
    Patent number: 7897347
    Abstract: A general immunoglobulin-target assay system is provided, in which a positive outcome (the generation of a signal) depends only on the intracellular interaction of immunoglobulin with target. This can be accomplished for many immunoglobulins expressed in yeast and/or in mammalian cells and allows the selection of immunoglobulins which are capable of functioning in an intracellular environment.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: March 1, 2011
    Assignees: Medical Research Council, Scuola Internazionale Superiore di Studi Avanzati
    Inventors: Wai-Choi Eric Tse, Terence Rabbits, Antonino Cattaneo, Michela Visintin
  • SELECTION OF INTRACELLULAR IMMUNOGLOBULINS
    Publication number: 20090317822
    Abstract: A general immunoglobulin-target assay system is provided, in which a positive outcome (the generation of a signal) depends only on the intracellular interaction of immunoglobulin with target. This can be accomplished for many immunoglobulins expressed in yeast and/or in mammalian cells and allows the selection of immunoglobulins which are capable of functioning in an intracellular environment.
    Type: Application
    Filed: July 31, 2009
    Publication date: December 24, 2009
    Applicants: MEDICAL RESEARCH COUNCIL, SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI
    Inventors: Wai-Choi Eric TSE, Terence RABBITS, Antonino CATTANEO, Michela VISINTIN